Hypoallergenicity of A Whey-Based, Extensively Hydrolysed Formula Containing Two Structurally Identical Human Milk Oligosaccharides
Abstract:
To determine whether an extensively hydrolyzed formula (EHF) supplemented with two human milk oligosaccharides (HMO) was tolerated by infants with cow’s milk protein allergy (CMPA).
Methods:
A whey-based EHF (Test formula) containing 2′fucosyl-lactose (2′FL) and lacto-N-neotetraose (LNnT) was assessed for clinical hypoallergenicity and safety. The Control formula was a cur...
Tags
This article's user rating is
Authors
Professor Anna Nowak-Wegrzyn
Dr Laura Czerkies
Kemuel Reyes
Dr Barbara Collins
Dr Ralf G. Heine
Related case studies
Professor Liam O'Mahony
Dr Harald Renz
Dr Elizabeth Forbes-Blom
Professor Ann Nowak-Wergrzyn
Dr. Bodo Niggemann
Dr. Andrea von Berg
Dr. Dietrich Berdel
Dr. U Schauer
Dr. Christoph Rieger
Dr. Elisabeth Haschke-Becher
Professor Ulrich Wahn
Professor Antonella Muraro
Professor Yvan Vandenplas
Related Content
Herentry K, et al
Rofes L, et al
Professor Liam O'Mahony
Dr Harald Renz
Dr Elizabeth Forbes-Blom
Professor Ann Nowak-Wergrzyn
Related Products
